EWA
AVXL icon

EverSource Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History

EverSource Wealth Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91K Buy
1,511
+258
+21% +$763 ﹤0.01% 3408
2026
Q1 		$3.85K Buy
+1,253
New +$5.43K ﹤0.01% 3384
2025
Q4 		– Sell
-55
Closed -$490 – 4288
2025
Q3 		$490 Sell
55
-23
-29% -$233 ﹤0.01% 3956
2025
Q2 		$719 Buy
78
+45
+136% +$384 ﹤0.01% 3810
2025
Q1 		$283 Buy
+33
New +$312 ﹤0.01% 3613

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EverSource Wealth Advisors's AVXL Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Anavex Life Sciences (AVXL) stake by 21% in Q2 2026, buying an estimated $763 and bringing the position to 1,511 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

EverSource Wealth Advisors first reported a position in AVXL in Q1 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • EverSource Wealth Advisors held 1,511 shares of Anavex Life Sciences worth $3.91K as of Q2 2026.
  • EverSource Wealth Advisors bought 258 Anavex Life Sciences shares in Q2 2026, an estimated $763.
  • Anavex Life Sciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3408 holding.
  • EverSource Wealth Advisors first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.